Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Genomic Health

Explore full profile

About Genomic Health Genomic Health, Inc

Redwood City, United StatesFounded 2000Biotech & Life Sciences
Valuation $2.80B Market cap · 2026
Revenue $394M Latest reported FY
EBITDA $86M Latest reported FY

At a glance

Founded
2000
Headquarters
Redwood City, United States
Listing
IPO 2005
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later1 investor entered at this stage

Employees mapped 321 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 33 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
10 countries with
team presence
🇺🇸 United States87.9%
🇨🇦 Canada3%
🇨🇭 Switzerland2.3%
🇵🇪 Peru0.8%
🇦🇷 Argentina0.8%
Top 5 of 10 shown
Web traffic by country
4.7K monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Patents

Estimated portfolio value
$79M

23 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Genomic Health was the backer or acquirer, 2013–2018. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Genomic Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Genomic Health deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Genomic Health's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Genomic Health on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Genomic Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.